January 2017

The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.

Prof. Myint, who co-designed the trial and will coordinate in the UK, says they “are applying to include OPERA in the NIHR portfolio” this year which enable the 4 existing Papillon sites to add their patients to this important study.

For more information on OPERA and it’s patient protocols please Contact us.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *